These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 10188964

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Effect of acute, short- and long-term milnacipran administration on rat locus coeruleus noradrenergic and dorsal raphe serotonergic neurons.
    Mongeau R, Weiss M, de Montigny C, Blier P.
    Neuropharmacology; 1998 Jul; 37(7):905-18. PubMed ID: 9776386
    [Abstract] [Full Text] [Related]

  • 4. Venlafaxine: discrepancy between in vivo 5-HT and NE reuptake blockade and affinity for reuptake sites.
    Béïque JC, de Montigny C, Blier P, Debonnel G.
    Synapse; 1999 Jun 01; 32(3):198-211. PubMed ID: 10340630
    [Abstract] [Full Text] [Related]

  • 5. Effects of sustained administration of the serotonin and norepinephrine reuptake inhibitor venlafaxine: I. in vivo electrophysiological studies in the rat.
    Béïque J, de Montigny C, Blier P, Debonnel G.
    Neuropharmacology; 2000 Jul 24; 39(10):1800-12. PubMed ID: 10884561
    [Abstract] [Full Text] [Related]

  • 6. alpha(2)-Adrenoceptor involvement in the in vitro inhibitory effect of citalopram on a subpopulation of rat locus coeruleus neurons.
    Grandoso L, Torrecilla M, Pineda J, Ugedo L.
    Eur J Pharmacol; 2005 Jul 04; 517(1-2):51-8. PubMed ID: 15975573
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Effect of the selective noradrenergic reuptake inhibitor reboxetine on the firing activity of noradrenaline and serotonin neurons.
    Szabo ST, Blier P.
    Eur J Neurosci; 2001 Jun 04; 13(11):2077-87. PubMed ID: 11422448
    [Abstract] [Full Text] [Related]

  • 12. Effects of the co-administration of mirtazapine and paroxetine on serotonergic neurotransmission in the rat brain.
    Besson A, Haddjeri N, Blier P, de Montigny C.
    Eur Neuropsychopharmacol; 2000 May 04; 10(3):177-88. PubMed ID: 10793320
    [Abstract] [Full Text] [Related]

  • 13. 5-HT1A autoreceptors and the mode of action of selective serotonin reuptake inhibitors (SSRI).
    Hjorth S, Auerbach SB.
    Behav Brain Res; 1996 May 04; 73(1-2):281-3. PubMed ID: 8788519
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Allosteric modulation of the effect of escitalopram, paroxetine and fluoxetine: in-vitro and in-vivo studies.
    Mansari ME, Wiborg O, Mnie-Filali O, Benturquia N, Sánchez C, Haddjeri N.
    Int J Neuropsychopharmacol; 2007 Feb 04; 10(1):31-40. PubMed ID: 16448580
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Paroxetine-induced increase in activity of locus coeruleus neurons in adolescent rats: implication of a countertherapeutic effect of an antidepressant.
    West CH, Ritchie JC, Weiss JM.
    Neuropsychopharmacology; 2010 Jul 04; 35(8):1653-63. PubMed ID: 20357759
    [Abstract] [Full Text] [Related]

  • 19. Interaction between a selective 5-HT1A receptor antagonist and an SSRI in vivo: effects on 5-HT cell firing and extracellular 5-HT.
    Gartside SE, Umbers V, Hajós M, Sharp T.
    Br J Pharmacol; 1995 Jul 04; 115(6):1064-70. PubMed ID: 7582504
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.